These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 30642945)

  • 1. Gene therapy targeting SARM1 blocks pathological axon degeneration in mice.
    Geisler S; Huang SX; Strickland A; Doan RA; Summers DW; Mao X; Park J; DiAntonio A; Milbrandt J
    J Exp Med; 2019 Feb; 216(2):294-303. PubMed ID: 30642945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons.
    Sasaki Y; Engber TM; Hughes RO; Figley MD; Wu T; Bosanac T; Devraj R; Milbrandt J; Krauss R; DiAntonio A
    Exp Neurol; 2020 Jul; 329():113252. PubMed ID: 32087251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy.
    Bosanac T; Hughes RO; Engber T; Devraj R; Brearley A; Danker K; Young K; Kopatz J; Hermann M; Berthemy A; Boyce S; Bentley J; Krauss R
    Brain; 2021 Nov; 144(10):3226-3238. PubMed ID: 33964142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinic acid mononucleotide is an allosteric SARM1 inhibitor promoting axonal protection.
    Sasaki Y; Zhu J; Shi Y; Gu W; Kobe B; Ve T; DiAntonio A; Milbrandt J
    Exp Neurol; 2021 Nov; 345():113842. PubMed ID: 34403688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program.
    Geisler S; Doan RA; Cheng GC; Cetinkaya-Fisgin A; Huang SX; Höke A; Milbrandt J; DiAntonio A
    JCI Insight; 2019 Sep; 4(17):. PubMed ID: 31484833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD
    Sasaki Y; Nakagawa T; Mao X; DiAntonio A; Milbrandt J
    Elife; 2016 Oct; 5():. PubMed ID: 27735788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARM1 is a metabolic sensor activated by an increased NMN/NAD
    Figley MD; Gu W; Nanson JD; Shi Y; Sasaki Y; Cunnea K; Malde AK; Jia X; Luo Z; Saikot FK; Mosaiab T; Masic V; Holt S; Hartley-Tassell L; McGuinness HY; Manik MK; Bosanac T; Landsberg MJ; Kerry PS; Mobli M; Hughes RO; Milbrandt J; Kobe B; DiAntonio A; Ve T
    Neuron; 2021 Apr; 109(7):1118-1136.e11. PubMed ID: 33657413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic diversity of axon degenerative mechanisms in models of Parkinson's disease.
    Peters OM; Weiss A; Metterville J; Song L; Logan R; Smith GA; Schwarzschild MA; Mueller C; Brown RH; Freeman M
    Neurobiol Dis; 2021 Jul; 155():105368. PubMed ID: 33892050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARM1 is required in human derived sensory neurons for injury-induced and neurotoxic axon degeneration.
    Chen YH; Sasaki Y; DiAntonio A; Milbrandt J
    Exp Neurol; 2021 May; 339():113636. PubMed ID: 33548217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARM1 activation triggers axon degeneration locally via NAD⁺ destruction.
    Gerdts J; Brace EJ; Sasaki Y; DiAntonio A; Milbrandt J
    Science; 2015 Apr; 348(6233):453-7. PubMed ID: 25908823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice.
    Geisler S; Doan RA; Strickland A; Huang X; Milbrandt J; DiAntonio A
    Brain; 2016 Dec; 139(Pt 12):3092-3108. PubMed ID: 27797810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD
    Essuman K; Summers DW; Sasaki Y; Mao X; DiAntonio A; Milbrandt J
    Neuron; 2017 Mar; 93(6):1334-1343.e5. PubMed ID: 28334607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARM1-Dependent Axon Degeneration: Nucleotide Signaling, Neurodegenerative Disorders, Toxicity, and Therapeutic Opportunities.
    McGuinness HY; Gu W; Shi Y; Kobe B; Ve T
    Neuroscientist; 2024 Aug; 30(4):473-492. PubMed ID: 37002660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARM1 acts downstream of neuroinflammatory and necroptotic signaling to induce axon degeneration.
    Ko KW; Milbrandt J; DiAntonio A
    J Cell Biol; 2020 Aug; 219(8):. PubMed ID: 32609299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic inactivation of SARM1 axon degeneration pathway improves outcome trajectory after experimental traumatic brain injury based on pathological, radiological, and functional measures.
    Bradshaw DV; Knutsen AK; Korotcov A; Sullivan GM; Radomski KL; Dardzinski BJ; Zi X; McDaniel DP; Armstrong RC
    Acta Neuropathol Commun; 2021 May; 9(1):89. PubMed ID: 34001261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Context-Specific Stress Causes Compartmentalized SARM1 Activation and Local Degeneration in Cortical Neurons.
    Hinz FI; Villegas CLM; Roberts JT; Yao H; Gaddam S; Delwig A; Green SA; Fredrickson C; Adrian M; Asuncion RR; Cheung TK; Hayne M; Hackos DH; Rose CM; Richmond D; Hoogenraad CC
    J Neurosci; 2024 Jun; 44(24):. PubMed ID: 38692735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarm1-mediated axon degeneration requires both SAM and TIR interactions.
    Gerdts J; Summers DW; Sasaki Y; DiAntonio A; Milbrandt J
    J Neurosci; 2013 Aug; 33(33):13569-80. PubMed ID: 23946415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Sarm1 does not suppress motor neuron degeneration in the SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Peters OM; Lewis EA; Osterloh JM; Weiss A; Salameh JS; Metterville J; Brown RH; Freeman MR
    Hum Mol Genet; 2018 Nov; 27(21):3761-3771. PubMed ID: 30010873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axon degeneration: mechanistic insights lead to therapeutic opportunities for the prevention and treatment of peripheral neuropathy.
    DiAntonio A
    Pain; 2019 May; 160 Suppl 1(Suppl 1):S17-S22. PubMed ID: 31008845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotoxin-mediated potent activation of the axon degeneration regulator SARM1.
    Loreto A; Angeletti C; Gu W; Osborne A; Nieuwenhuis B; Gilley J; Merlini E; Arthur-Farraj P; Amici A; Luo Z; Hartley-Tassell L; Ve T; Desrochers LM; Wang Q; Kobe B; Orsomando G; Coleman MP
    Elife; 2021 Dec; 10():. PubMed ID: 34870595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.